Literature DB >> 27536412

Crystal structure of bergapten: a photomutagenic and photobiologically active furan-ocoumarin.

A K Bauri1, Sabine Foro2, Quynh Nguyen Nhu Do3.   

Abstract

The title compound, C12H8O4, is a furan-ocoumarin [systematic name: 4-meth-oxy-7H-furo[3,2-g]chromen-7-one], which was isolated from the Indian herb T. stictocarpum. The mol-ecule is almost planar with an r.m.s. deviation of 0.024 Å for the hetero atoms of the fused-ring system. In the crystal, mol-ecules are linked by C-H⋯O hydrogen bonds, forming a three-dimensional framework. There are offset π-π inter-actions present involving the coumarin moieties stacking along the a-axis direction [shortest inter-centroid distance = 3.717 (3) Å].

Entities:  

Keywords:  C—H⋯O hydrogen bonds; T. sticto­carpum; bergapten; crystal structure; furan­ocoumarin; photobiological activity; psoralen; π–π inter­actions

Year:  2016        PMID: 27536412      PMCID: PMC4971871          DOI: 10.1107/S2056989016011221

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

The title mol­ecule, bergapten, is a linear furan­ocoumarin having a meth­oxy group in the benzene ring at position C5. This class of furano coumarins have absorption bands in the near UV region due to the presence of conjugated double bonds, and exhibit photomutagenic (Appendino, et al., 2004 ▸) and photocarcinogenic properties, binding with purine bases of DNA in living cells to yield photoadducts (Filomena et al., 2009 ▸). Based on this property, they are employed to treat numerous inflammatory skin diseases, such as atopic dermatitis, and pigment disorders like vitiligo and psoriasis by UV photodynamic therapy. In addition, due to their strong ability to absorb UV radiation, this class of mol­ecules are utilized as photoprotective agents, to prevent the absorption of harmful UV radiation by the skin. A variety of sun-screen lotions are widely used in dermatological applications in the cosmetic and pharmaceutical industries (Chen et al., 2007 ▸, 2009 ▸). In addition, the in vitro anti­proliferation activity and in vivo photoxicity of the title mol­ecule has been reported against epithelial cancer cell lines, including HL60, A431 (Conconi et al., 1998 ▸). Bergapten (5-meth­oxy psoralen/methoxsalen) has been used successfully in combination with UV photodynamic therapy to mange psoriasis and vitiligo; it inhibits proliferation in human hepatocellular carcinoma cell line (March et al., 1993 ▸). Experimental results revealed that its phototoxicity and photomutagenicity is exerted via a Diels–Alder reaction binding the double bond of a purine base of DNA in a living cell with the double bonds of bergapten to yield mono- and di-adducts (Conforti et al., 2009 ▸). While this is the first report of the crystal structure of the title compound, its chemical structure was determined by spectrometric and spectroscopic analysis many years ago (Howell & Robertson, 1937 ▸; Ray et al., 1937 ▸; Lin et al., 1979 ▸; Confalone & Confalone, 1983 ▸).

Structural commentary

The title compound (Fig. 1 ▸), belongs to the psoralen class of compounds and is composed of three fused rings viz. furan, benzene and pyrone. It is an almost planar mol­ecule with an r.m.s. deviation of 0.024 Å for the atoms of the fused ring system, O1–O2/C1–C11. The meth­oxy C atom, C12, is displaced from this mean plane by 0.925 (5) Å, while atoms O3 and O4 are displaced from the mean plane by 0.069 (3) and 0.035 (3) Å, respectively.
Figure 1

A view of the mol­ecular structure of the title compound, with the atom labelling. Displacement ellipsoids are drawn at the 50% probability level.

Supra­molecular features

In the crystal, mol­ecules are linked by a series of C—H⋯O hydrogen bonds, which are illustrated in Fig. 2 ▸ (see also Table 1 ▸). They form a three-dimensional network (Table 1 ▸ and Fig. 3 ▸). There are offset π–π inter­actions present involving the coumarin moieties stacking along the a-axis direction [shortest inter-centroid distance Cg2⋯Cg3i = 3.717 (3) Å, inter­planar distance = 3.425 (2) Å, slippage = 1.356 Å, Cg2 and Cg3 are the centroids of rings O2/C6/C7/C9–C11 and C1/C4–C8, respectively, symmetry code: (i) x − 1, y, z].
Figure 2

A view of the various C—H⋯O hydrogen bonds (dashed lines; see Table 1 ▸ for details) in the crystal of the title compound.

Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
C2—H2⋯O3i 0.932.493.406 (5)170
C3—H3⋯O4ii 0.932.573.484 (6)170
C10—H10⋯O4iii 0.932.513.387 (5)158
C12—H12A⋯O4ii 0.962.443.376 (5)165

Symmetry codes: (i) ; (ii) ; (iii) .

Figure 3

A view along the a axis of the crystal packing of the title compound. Hydrogen bonds are drawn as dashed lines (see Table 1 ▸) and H atoms not involved in these inter­actions have been omitted for clarity.

Database survey

A search of the Cambridge Structural Database (CSD, Version 5.37, last update May 2016; Groom et al., 2016 ▸) gave 16 hits for the furan­ocoumarin skeleton with an O atom substituent in position 5, similar to the title compound. Two compounds closely resemble the title compound, viz. 5-hy­droxy­psolalen [JIXBOH; Ginderow, 1991 ▸] isolated from the bark of Citrus bergamia, and 5,8-di­meth­oxy­psoralen [ISIMP (293 K); Gopalakrishna et al., 1977 ▸] and [ISIMP01 (120 K); Napolitano et al., 2003 ▸]. The latter was isolated from the roots and leaves of Adiscanthus fusciflorus (Rutaceae).

Synthesis and crystallization

The title compound was isolated as a colourless solid from the methanol extract of T. stictocarpum by means of column chromatography over silica gel by gradient elution with a mixture of binary solvents system hexane and ethyl acetate. It was purified by reverse phase high-pressure liquid chromatography. Colourless rod-like crystals, suitable crystals for X ray diffraction analysis, were obtained after the title compound was recrystallized three times from ethyl acetate:hexane (1:4) mixed solvents at room temperature by slow evaporation of the solvents (m.p. 469 K). 1H NMR data (CHCl3, 200 MHz) 8.13 (d, 1H, J = 9.8 Hz, H-9), 7.57 (d, 1H, J = 2.2 Hz, H-2), 7.11 (s, 1H, H-8), 7.05 (d, 1H, J = 2.2 Hz, H-3), 6.25 (d, 1H, J = 9.8 Hz, H-10), 4.26 (s, 3H, OCH3). EIMS (70 ev) data: m/z (%) 216 (100; base peak/mol­ecular ion peak) [M +], 201 (25.2%) [M +−CH3), 188 (25.7) [M +−OCH3], 173 (25.6) [M +−(CH3–CO)], 145 (33.8) [M +−(OCH3–CO2)], 89(17.0).

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. The C-bound H atoms were included in calculated positions and treated as riding atoms: C—H = 0.93–0.96 Å with U iso(H) = 1.5U eq(C-meth­yl) and 1.2Ueq(C) for other H atoms. The structure was refined as a two-component twin [180° rotation about the a* axis; BASF = 0.3955 (2)].
Table 2

Experimental details

Crystal data
Chemical formulaC12H8O4
M r 216.18
Crystal system, space groupMonoclinic, P21/c
Temperature (K)299
a, b, c (Å)3.8486 (8), 14.676 (2), 16.866 (3)
β (°)92.12 (2)
V3)952.0 (3)
Z 4
Radiation typeMo Kα
μ (mm−1)0.12
Crystal size (mm)0.44 × 0.08 × 0.02
 
Data collection
DiffractometerOxford Diffraction Xcalibur with a Sapphire CCD detector
Absorption correctionMulti-scan (CrysAlis RED; Oxford Diffraction, 2009)’
T min, T max 0.951, 0.998
No. of measured, independent and observed [I > 2σ(I)] reflections7096, 7096, 3811
R int 0.08
(sin θ/λ)max−1)0.602
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.055, 0.138, 0.86
No. of reflections7096
No. of parameters147
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å−3)0.19, −0.22

Computer programs: CrysAlis CCD and CrysAlis RED (Oxford Diffraction, 2009 ▸), SHELXS2014 (Sheldrick, 2008 ▸), SHELXL2014 (Sheldrick, 2015 ▸) and PLATON (Spek, 2009 ▸).

Crystal structure: contains datablock(s) I, Global. DOI: 10.1107/S2056989016011221/su5310sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989016011221/su5310Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989016011221/su5310Isup3.cml CCDC reference: 1491854 Additional supporting information: crystallographic information; 3D view; checkCIF report
C12H8O4Dx = 1.508 Mg m3
Mr = 216.18Melting point: 469 K
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
a = 3.8486 (8) ÅCell parameters from 870 reflections
b = 14.676 (2) Åθ = 2.8–27.9°
c = 16.866 (3) ŵ = 0.12 mm1
β = 92.12 (2)°T = 299 K
V = 952.0 (3) Å3Needle, colourless
Z = 40.44 × 0.08 × 0.02 mm
F(000) = 448
Oxford Diffraction Xcalibur with a Sapphire CCD detector diffractometer7096 independent reflections
Radiation source: fine-focus sealed tube3811 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.08
Rotation method data acquisition using ω and phi scans.θmax = 25.4°, θmin = 2.8°
Absorption correction: multi-scan (CrysAlis RED; Oxford Diffraction, 2009)'h = −4→4
Tmin = 0.951, Tmax = 0.998k = −17→17
7096 measured reflectionsl = −20→20
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.055Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.138H-atom parameters constrained
S = 0.86w = 1/[σ2(Fo2) + (0.0738P)2] where P = (Fo2 + 2Fc2)/3
7096 reflections(Δ/σ)max = 0.002
147 parametersΔρmax = 0.19 e Å3
0 restraintsΔρmin = −0.22 e Å3
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refined as a 2-component twin.
xyzUiso*/Ueq
O10.7447 (9)0.00489 (18)0.37565 (18)0.0525 (10)
O20.3156 (8)0.26727 (18)0.50579 (14)0.0399 (9)
O30.7860 (9)0.28906 (17)0.24893 (16)0.0510 (10)
O40.1046 (9)0.3863 (2)0.56614 (18)0.0617 (11)
C10.6682 (13)0.0956 (3)0.3822 (3)0.0392 (13)
C20.8854 (13)−0.0043 (3)0.3016 (3)0.0534 (15)
H20.9619−0.05950.28140.064*
C30.8989 (13)0.0740 (3)0.2626 (3)0.0477 (14)
H30.98320.08330.21230.057*
C40.7573 (13)0.1417 (3)0.3137 (2)0.0369 (12)
C50.6975 (12)0.2354 (3)0.3111 (2)0.0344 (12)
C60.5523 (11)0.2781 (3)0.3757 (2)0.0304 (11)
C70.4677 (11)0.2262 (3)0.4418 (2)0.0348 (12)
C80.5234 (12)0.1339 (3)0.4477 (3)0.0397 (13)
H80.46790.10030.49220.048*
C90.4692 (12)0.3738 (3)0.3771 (3)0.0373 (13)
H90.52210.41010.33390.045*
C100.3191 (12)0.4114 (3)0.4385 (2)0.0431 (13)
H100.26540.47320.43710.052*
C110.2370 (13)0.3592 (3)0.5074 (3)0.0433 (13)
C120.6549 (14)0.2653 (3)0.1726 (2)0.0652 (17)
H12A0.79360.21730.15160.098*
H12B0.66300.31750.13840.098*
H12C0.41870.24500.17580.098*
U11U22U33U12U13U23
O10.075 (3)0.0265 (17)0.056 (2)0.0074 (19)0.006 (2)−0.0024 (16)
O20.054 (2)0.0343 (18)0.0321 (16)0.0034 (18)0.0073 (19)0.0003 (14)
O30.081 (3)0.0419 (18)0.0300 (17)−0.0206 (19)0.005 (2)0.0006 (15)
O40.089 (3)0.052 (2)0.045 (2)0.018 (2)0.025 (2)−0.0027 (18)
C10.045 (4)0.029 (3)0.043 (3)0.000 (3)−0.007 (3)0.000 (2)
C20.063 (4)0.040 (3)0.058 (3)0.009 (3)0.010 (3)−0.013 (3)
C30.054 (4)0.041 (3)0.048 (3)−0.001 (3)0.007 (3)−0.006 (2)
C40.040 (3)0.032 (3)0.039 (3)−0.002 (3)−0.001 (3)−0.0073 (19)
C50.036 (3)0.037 (3)0.030 (2)−0.006 (3)0.001 (3)0.001 (2)
C60.029 (3)0.029 (2)0.033 (2)−0.002 (2)−0.002 (2)−0.001 (2)
C70.041 (3)0.033 (3)0.031 (2)−0.002 (3)0.005 (2)−0.002 (2)
C80.049 (4)0.033 (3)0.038 (3)−0.002 (3)0.004 (3)0.008 (2)
C90.047 (3)0.030 (3)0.035 (3)−0.004 (2)0.002 (3)0.005 (2)
C100.056 (4)0.029 (2)0.044 (3)0.004 (3)0.001 (3)0.003 (2)
C110.046 (4)0.036 (3)0.048 (3)0.007 (3)0.006 (3)−0.001 (2)
C120.099 (5)0.060 (3)0.037 (3)−0.013 (4)0.001 (3)−0.003 (2)
O1—C11.369 (5)C4—C51.394 (6)
O1—C21.386 (5)C5—C61.391 (5)
O2—C71.385 (4)C6—C71.398 (5)
O2—C111.383 (5)C6—C91.442 (5)
O3—C51.365 (4)C7—C81.374 (5)
O3—C121.409 (4)C8—H80.9300
O4—C111.200 (5)C9—C101.325 (5)
C1—C81.376 (5)C9—H90.9300
C1—C41.393 (6)C10—C111.435 (5)
C2—C31.327 (6)C10—H100.9300
C2—H20.9300C12—H12A0.9600
C3—C41.435 (6)C12—H12B0.9600
C3—H30.9300C12—H12C0.9600
C1—O1—C2105.1 (3)C8—C7—O2116.2 (4)
C7—O2—C11122.6 (3)C8—C7—C6123.7 (4)
C5—O3—C12117.9 (3)O2—C7—C6120.1 (4)
O1—C1—C8123.8 (4)C1—C8—C7114.2 (4)
O1—C1—C4110.2 (4)C1—C8—H8122.9
C8—C1—C4126.0 (4)C7—C8—H8122.9
C3—C2—O1112.7 (4)C10—C9—C6121.4 (4)
C3—C2—H2123.7C10—C9—H9119.3
O1—C2—H2123.7C6—C9—H9119.3
C2—C3—C4106.2 (4)C9—C10—C11121.7 (4)
C2—C3—H3126.9C9—C10—H10119.1
C4—C3—H3126.9C11—C10—H10119.1
C5—C4—C1117.3 (4)O4—C11—O2116.1 (4)
C5—C4—C3136.9 (4)O4—C11—C10127.2 (4)
C1—C4—C3105.8 (4)O2—C11—C10116.8 (4)
O3—C5—C6117.4 (4)O3—C12—H12A109.5
O3—C5—C4123.2 (4)O3—C12—H12B109.5
C6—C5—C4119.4 (4)H12A—C12—H12B109.5
C5—C6—C7119.4 (4)O3—C12—H12C109.5
C5—C6—C9123.2 (4)H12A—C12—H12C109.5
C7—C6—C9117.4 (4)H12B—C12—H12C109.5
C2—O1—C1—C8−179.8 (5)C4—C5—C6—C9−177.6 (4)
C2—O1—C1—C40.3 (5)C11—O2—C7—C8−178.5 (4)
C1—O1—C2—C3−0.2 (6)C11—O2—C7—C60.9 (6)
O1—C2—C3—C40.0 (6)C5—C6—C7—C80.8 (6)
O1—C1—C4—C5−179.6 (4)C9—C6—C7—C8178.3 (4)
C8—C1—C4—C50.5 (7)C5—C6—C7—O2−178.5 (4)
O1—C1—C4—C3−0.3 (5)C9—C6—C7—O2−1.1 (6)
C8—C1—C4—C3179.8 (5)O1—C1—C8—C7−179.9 (5)
C2—C3—C4—C5179.2 (6)C4—C1—C8—C7−0.1 (7)
C2—C3—C4—C10.2 (6)O2—C7—C8—C1178.7 (4)
C12—O3—C5—C6−126.8 (4)C6—C7—C8—C1−0.6 (7)
C12—O3—C5—C455.5 (6)C5—C6—C9—C10177.4 (5)
C1—C4—C5—O3177.3 (4)C7—C6—C9—C100.1 (7)
C3—C4—C5—O3−1.7 (9)C6—C9—C10—C111.1 (7)
C1—C4—C5—C6−0.3 (7)C7—O2—C11—O4179.7 (4)
C3—C4—C5—C6−179.3 (5)C7—O2—C11—C100.3 (6)
O3—C5—C6—C7−178.0 (4)C9—C10—C11—O4179.3 (5)
C4—C5—C6—C7−0.3 (6)C9—C10—C11—O2−1.3 (7)
O3—C5—C6—C94.7 (6)
D—H···AD—HH···AD···AD—H···A
C2—H2···O3i0.932.493.406 (5)170
C3—H3···O4ii0.932.573.484 (6)170
C10—H10···O4iii0.932.513.387 (5)158
C12—H12A···O4ii0.962.443.376 (5)165
  9 in total

1.  Fingerprint analysis of the fruits of Cnidium monnieri extract by high-performance liquid chromatography-diode array detection-electrospray ionization tandem mass spectrometry.

Authors:  Yi Chen; Guorong Fan; Qiaoyan Zhang; Huiling Wu; Yutian Wu
Journal:  J Pharm Biomed Anal       Date:  2006-10-13       Impact factor: 3.935

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Antiproliferative activity and phototoxicity of some methyl derivatives of 5-methoxypsoralen and 5-methoxyangelicin.

Authors:  M T Conconi; F Montesi; P P Parnigotto
Journal:  Pharmacol Toxicol       Date:  1998-04

4.  Separation and determination of coumarins in Fructus cnidii extracts by pressurized capillary electrochromatography using a packed column with a monolithic outlet frit.

Authors:  Danxia Chen; Jiajing Wang; Yunyun Jiang; Tingting Zhou; Guorong Fan; Yutian Wu
Journal:  J Pharm Biomed Anal       Date:  2009-05-30       Impact factor: 3.935

5.  Coumarins from Opopanax chironium. New dihydrofuranocoumarins and differential induction of apoptosis by imperatorin and heraclenin.

Authors:  Giovanni Appendino; Federica Bianchi; Ammar Bader; Claudio Campagnuolo; Ernesto Fattorusso; Orazio Taglialatela-Scafati; Magdalena Blanco-Molina; Antonio Macho; Bernd L Fiebich; Paul Bremner; Michael Heinrich; Mauro Ballero; Eduardo Muñoz
Journal:  J Nat Prod       Date:  2004-04       Impact factor: 4.050

6.  8-Methoxypsoralen and longwave ultraviolet irradiation are a novel antiproliferative combination for vascular smooth muscle.

Authors:  K L March; B L Patton; R L Wilensky; D R Hathaway
Journal:  Circulation       Date:  1993-01       Impact factor: 29.690

7.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

8.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20

9.  The Cambridge Structural Database.

Authors:  Colin R Groom; Ian J Bruno; Matthew P Lightfoot; Suzanna C Ward
Journal:  Acta Crystallogr B Struct Sci Cryst Eng Mater       Date:  2016-04-01
  9 in total
  3 in total

Review 1.  Pharmacological Properties of Bergapten: Mechanistic and Therapeutic Aspects.

Authors:  Maria Magdalena Quetglas-Llabrés; Cristina Quispe; Jesús Herrera-Bravo; Marcelo D Catarino; Olívia R Pereira; Susana M Cardoso; Kamal Dua; Dinesh Kumar Chellappan; Kavita Pabreja; Saurabh Satija; Meenu Mehta; Antoni Sureda; Miquel Martorell; Dinara Satmbekova; Balakyz Yeskaliyeva; Javad Sharifi-Rad; Naeem Rasool; Monica Butnariu; Iulia Cristina Bagiu; Radu Vasile Bagiu; Daniela Calina; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2022-04-25       Impact factor: 7.310

2.  Defined Small Molecules Produced by Himalayan Medicinal Plants Display Immunomodulatory Properties.

Authors:  Phurpa Wangchuk; Simon H Apte; Michael J Smout; Penny L Groves; Alex Loukas; Denise L Doolan
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

3.  Tracing the Photoaddition of Pharmaceutical Psoralens to DNA.

Authors:  Janina Diekmann; Isabell Theves; Kristoffer A Thom; Peter Gilch
Journal:  Molecules       Date:  2020-11-10       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.